Article Details

Sierra Oncology (SRRA) Rating Increased to Hold at Zacks Investment Research

Retrieved on: 2018-10-10 08:56:15

Tags for this article:

Click the tags to see associated articles and topics

Sierra Oncology (SRRA) Rating Increased to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in Sierra Oncology in the 1st quarter worth about $203,000. Finally, Candriam Luxembourg S.C.A. ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo